Shopping Cart 0
Cart Subtotal
AED 0

Laboratory Corp of America Holdings (LH) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics laboratory services such as core testing, genomic and esoteric testing. Its services include general and specialty laboratory testing, ambulatory monitoring services, bone marrow and human leukocyte antigen (HLA) testing, clinical trials services, drug testing services, DNA identification services, forensic identity services, insurance health plan services, paternity testing services, patient services, personalized medicine and hospital services. It also offers drug development services through Covance. It offers its services to managed care organizations, physicians, hospitals, government agencies and biotechnology and pharmaceutical companies through a network of primary laboratories and patient service centers. The company has operations across the US, Columbia, Belgium, Puerto Rico, Japan, China, Singapore, the UK and three Canadian provinces. LabCorp is headquartered in Burlington, North Carolina, the US.

Laboratory Corp of America Holdings (LH)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 6

List of Figures 7

Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Laboratory Corp of America Holdings, Medical Equipment Deals By Type, 2012 to YTD 2018 9

Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Laboratory Corp of America Holdings, Medical Equipment, Deals By Market, 2012 to YTD 2018 11

Laboratory Corp of America Holdings, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

Laboratory Corp of America Holdings, Medical Equipment, Deal Details 17

Asset Purchase 17

Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 17

Pharma Tech Solutions Acquires Genstrip From Shasta Technologies 19

Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For USD 1.3 Million 20

Venture Financing 21

Orig3n Raises Funds through Initial Closing of Series B Financing 21

OmniSeq Plans to Raise Funds through Series B Financing 23

Sera Prognostics Raises USD40 Million in Series C Financing 24

Seventh Sense Biosystems Raises USD10 Million in Series C Financing 25

Ativa Medical Raises USD15 Million in Series B Financing 27

Vivify Health Raises Funds in Series B Venture Financing 29

Seventh Sense Biosystems Raises USD16 Million in Series B Financing 30

Flatiron Health Raises USD 130 Million In Series B Financing 32

Flatiron Health Raises USD 8 Million In Series A Financing 34

Private Equity 36

Decision Diagnostics Plans to Raise USD4.7 Million in Financing 36

Partnerships 37

LabCorp Enters into Licensing Agreement with MDNA Life Sciences 37

Sequenom Enters into Licensing Agreement with Mayo Medical Labs 38

Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 39

Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 41

Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 42

LipoScience Enters Into Licensing Agreement With Cleveland Clinic 43

LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 44

Covance Enters into Strategic Technology Agreement with GlaxoSmithKline 45

MC10 Enters into Partnership with LabCorp 46

OmniSeq Enters into Distribution Agreement with Laboratory Corp of America 47

Sera Prognostics Enters into Agreement with LabCorp 48

Interpace Diagnostics Extends Agreement with LabCorp 49

Sequenom enters into an Agreement with University of California 50

Sysmex Enters into Co-Development Agreement with LabCorp 51

Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 52

Gamma-Dynacare Medical Labs Enters Into Agreement With OSR Medical 53

Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 54

Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 55

Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 56

CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests 57

CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests 58

Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 59

XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 60

Equity Offering 61

MC10 Raises Funds through Private Placement of Shares 61

LipoScience Completes IPO For USD 52 Million 62

Sequenom Completes Public Offering Of Common Stock For USD 62 Million 64

Debt Offering 66

LabCorp Raises USD600 Million in Public Offering of 3.6% Notes Due 2027 66

LabCorp Raises USD600 Million in Public Offering of 3.25% Notes Due 2024 68

LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 70

LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 72

LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 74

LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 76

LabCorp Completes Public Offering Of Notes Due 2018 For USD 400 Million 78

LabCorp Completes Public Offering Of Notes Due 2023 For USD 300 Million 80

Sequenom Completes Private Placement Of Notes Due 2017 For USD 130 Million 82

LabCorp Completes Public Offering Of Senior Notes Due 2017 For USD 500 Million 83

LabCorp Completes Public Offering Of Senior Notes Due 2022 For USD 500 Million 85

Asset Transactions 87

Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 87

Marken Acquires European Kit Building Operation Facility From LabCorp 88

Acquisition 89

Eurofins Acquires Covance from LabCorp 89

LabCorp Acquires Sciformix 91

LabCorp Acquires Pathology Associates Medical Labs from Providence Health & Services and Catholic Health Initiatives 92

LabCorp Acquires ClearPath Diagnostics from Shore Capital Partners 94

LabCorp Acquires Sequenom 95

LabCorp Acquires Covance for USD6.1 Billion 97

LabCorp Acquires Bode Technology from SolutionPoint 99

LabCorp Acquires LipoScience for USD85.3 Million 100

Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 102

Gamma-Dynacare Medical Labs Acquires Controlling Interest In Impact Genetics 103

LabCorp Acquires Minority Stake In SynapDx For USD 2 Million 104

LabCorp Completes Acquisition Of Medtox Scientific For USD 241 Million 105

Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 107

Laboratory Corp of America Holdings-Key Competitors 108

Laboratory Corp of America Holdings-Key Employees 109

Laboratory Corp of America Holdings-Locations And Subsidiaries 110

Head Office 110

Other Locations & Subsidiaries 110

Recent Developments 115

Strategy And Business Planning 115

Jun 01, 2018: LabCorp and Unilabs Collaborate to Expand Global Reach of Precision Medicine Capabilities to Serve Patients, Physicians and Pharma 115

Jun 14, 2017: Covance Opens State-of-the-Art Laboratory for Companion Diagnostics 116

Apr 21, 2017: Covance to Expand Large-Molecule Development Capabilities in the UK 117

Financial Announcements 118

Jul 25, 2018: LabCorp Announces 2018 Second Quarter Results and Updates 2018 Guidance 118

Apr 25, 2018: LabCorp Announces Strong 2018 First Quarter Results and Updates 2018 Guidance 120

Feb 06, 2018: LabCorp Reports Net Revenue Of USD 2.70 Billion In The Fourth Quarter 2017 123

Oct 25, 2017: LabCorp Announces Record Third Quarter Results and Increases 2017 Guidance 126

Jul 26, 2017: LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance 128

Apr 25, 2017: Laboratory Corporation of America Holdings Announces 2017 First Quarter Results and Updates 2017 Guidance 131

Feb 16, 2017: Laboratory Corporation of America Holdings Announces Record 2016 Fourth Quarter and Full Year Results and Provides 2017 Guidance 133

Corporate Communications 136

Jul 12, 2018: Robert E. Mittelstaedt, Jr. to Retire from LabCorp Board of Directors and Current Board Member Adam H. Schechter to Assume Role of Lead Independent Director in 2019 136

Nov 13, 2017: LabCorp Receives 2017 Partnership Award from Be The Match 137

Aug 24, 2017: LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer 138

Jul 18, 2017: LabCorp's William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center 139

Mar 29, 2017: LabCorp Promotes Executive Gary Huff to CEO of LabCorp Diagnostics, One of the Company's Two Primary Business Segments 140

Legal and Regulatory 141

Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 141

Product News 142

Nov 16, 2017: Cority Enhances Clinical Testing Solution with LabCorp Interface 142

Sep 14, 2017: LabCorp Presents Nine Studies, Including Novel Research on Improving Genetic Counseling Quality, at the National Society of Genetic Counselors Annual Conference 143

Apr 28, 2017: LabCorp to Exclusively Offer the M3 Checklist, a Multi-Condition Mental Health Screening Tool 144

Other Significant Developments 146

May 25, 2018: LabCorp to Become a Preferred National Laboratory for Aetna 146

May 01, 2018: LabCorp Announces Collaboration with The Recovery Platform to Assist Physicians Treating Patients with Opioid Dependency 147

Sep 25, 2017: LabCorp Objects to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests; Calls for Delay in Implementation to Avoid Significant Harm to Medicare Beneficiaries 148

Jul 11, 2017: LabCorp and Novant Health Extend Laboratory Services Agreement 149

Jun 28, 2017: Walgreens and LabCorp Collaborate to Bring Patient Service Centers for Laboratory Testing to Select Walgreens Stores 150

Appendix 151

Methodology 151

About GlobalData 151

Contact Us 151

Disclaimer 151


List Of Figure

List of Figures

Laboratory Corp of America Holdings, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Laboratory Corp of America Holdings, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Laboratory Corp of America Holdings, Medical Equipment, Deals by Type, 2012 to YTD 2018 9

Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Laboratory Corp of America Holdings, Medical Equipment, Deals by Market, 2012 to YTD 2018 11


List Of Table

List of Tables

Laboratory Corp of America Holdings, Medical Equipment, Key Facts, 2017 2

Laboratory Corp of America Holdings, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Laboratory Corp of America Holdings, Medical Equipment Deals By Type, 2012 to YTD 2018 9

Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Laboratory Corp of America Holdings, Deals By Market, 2012 to YTD 2018 11

Laboratory Corp of America Holdings, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 17

Pharma Tech Solutions Acquires Genstrip From Shasta Technologies 19

Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For USD 1.3 Million 20

Orig3n Raises Funds through Initial Closing of Series B Financing 21

OmniSeq Plans to Raise Funds through Series B Financing 23

Sera Prognostics Raises USD40 Million in Series C Financing 24

Seventh Sense Biosystems Raises USD10 Million in Series C Financing 25

Ativa Medical Raises USD15 Million in Series B Financing 27

Vivify Health Raises Funds in Series B Venture Financing 29

Seventh Sense Biosystems Raises USD16 Million in Series B Financing 30

Flatiron Health Raises USD 130 Million In Series B Financing 32

Flatiron Health Raises USD 8 Million In Series A Financing 34

Decision Diagnostics Plans to Raise USD4.7 Million in Financing 36

LabCorp Enters into Licensing Agreement with MDNA Life Sciences 37

Sequenom Enters into Licensing Agreement with Mayo Medical Labs 38

Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 39

Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 41

Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 42

LipoScience Enters Into Licensing Agreement With Cleveland Clinic 43

LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 44

Covance Enters into Strategic Technology Agreement with GlaxoSmithKline 45

MC10 Enters into Partnership with LabCorp 46

OmniSeq Enters into Distribution Agreement with Laboratory Corp of America 47

Sera Prognostics Enters into Agreement with LabCorp 48

Interpace Diagnostics Extends Agreement with LabCorp 49

Sequenom enters into an Agreement with University of California 50

Sysmex Enters into Co-Development Agreement with LabCorp 51

Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 52

Gamma-Dynacare Medical Labs Enters Into Agreement With OSR Medical 53

Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 54

Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 55

Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 56

CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests 57

CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests 58

Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 59

XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 60

MC10 Raises Funds through Private Placement of Shares 61

LipoScience Completes IPO For USD 52 Million 62

Sequenom Completes Public Offering Of Common Stock For USD 62 Million 64

LabCorp Raises USD600 Million in Public Offering of 3.6% Notes Due 2027 66

LabCorp Raises USD600 Million in Public Offering of 3.25% Notes Due 2024 68

LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 70

LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 72

LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 74

LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 76

LabCorp Completes Public Offering Of Notes Due 2018 For USD 400 Million 78

LabCorp Completes Public Offering Of Notes Due 2023 For USD 300 Million 80

Sequenom Completes Private Placement Of Notes Due 2017 For USD 130 Million 82

LabCorp Completes Public Offering Of Senior Notes Due 2017 For USD 500 Million 83

LabCorp Completes Public Offering Of Senior Notes Due 2022 For USD 500 Million 85

Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 87

Marken Acquires European Kit Building Operation Facility From LabCorp 88

Eurofins Acquires Covance from LabCorp 89

LabCorp Acquires Sciformix 91

LabCorp Acquires Pathology Associates Medical Labs from Providence Health & Services and Catholic Health Initiatives 92

LabCorp Acquires ClearPath Diagnostics from Shore Capital Partners 94

LabCorp Acquires Sequenom 95

LabCorp Acquires Covance for USD6.1 Billion 97

LabCorp Acquires Bode Technology from SolutionPoint 99

LabCorp Acquires LipoScience for USD85.3 Million 100

Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 102

Gamma-Dynacare Medical Labs Acquires Controlling Interest In Impact Genetics 103

LabCorp Acquires Minority Stake In SynapDx For USD 2 Million 104

LabCorp Completes Acquisition Of Medtox Scientific For USD 241 Million 105

Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 107

Laboratory Corp of America Holdings, Key Competitors 108

Laboratory Corp of America Holdings, Key Employees 109

Laboratory Corp of America Holdings, Other Locations 110

Laboratory Corp of America Holdings, Subsidiaries 111

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Laboratory Corp of America Holdings, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics laboratory services such as core testing, genomic and esoteric testing. Its services include general and specialty laboratory testing, ambulatory monitoring services, bone marrow and human leukocyte antigen (HLA) testing, clinical trials services, drug testing services, DNA identification services, forensic identity services, insurance health plan services, paternity testing services, patient services, personalized medicine and hospital services. It also offers drug development services through Covance. It offers its services to managed care organizations, physicians, hospitals, government agencies and biotechnology and pharmaceutical companies through a network of primary laboratories and patient service centers. The company has operations across the US, Columbia, Belgium, Puerto Rico, Japan, China, Singapore, the UK and three Canadian provinces. LabCorp is headquartered in Burlington, North Carolina, the US.

Laboratory Corp of America Holdings (LH)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 6

List of Figures 7

Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Laboratory Corp of America Holdings, Medical Equipment Deals By Type, 2012 to YTD 2018 9

Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Laboratory Corp of America Holdings, Medical Equipment, Deals By Market, 2012 to YTD 2018 11

Laboratory Corp of America Holdings, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

Laboratory Corp of America Holdings, Medical Equipment, Deal Details 17

Asset Purchase 17

Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 17

Pharma Tech Solutions Acquires Genstrip From Shasta Technologies 19

Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For USD 1.3 Million 20

Venture Financing 21

Orig3n Raises Funds through Initial Closing of Series B Financing 21

OmniSeq Plans to Raise Funds through Series B Financing 23

Sera Prognostics Raises USD40 Million in Series C Financing 24

Seventh Sense Biosystems Raises USD10 Million in Series C Financing 25

Ativa Medical Raises USD15 Million in Series B Financing 27

Vivify Health Raises Funds in Series B Venture Financing 29

Seventh Sense Biosystems Raises USD16 Million in Series B Financing 30

Flatiron Health Raises USD 130 Million In Series B Financing 32

Flatiron Health Raises USD 8 Million In Series A Financing 34

Private Equity 36

Decision Diagnostics Plans to Raise USD4.7 Million in Financing 36

Partnerships 37

LabCorp Enters into Licensing Agreement with MDNA Life Sciences 37

Sequenom Enters into Licensing Agreement with Mayo Medical Labs 38

Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 39

Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 41

Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 42

LipoScience Enters Into Licensing Agreement With Cleveland Clinic 43

LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 44

Covance Enters into Strategic Technology Agreement with GlaxoSmithKline 45

MC10 Enters into Partnership with LabCorp 46

OmniSeq Enters into Distribution Agreement with Laboratory Corp of America 47

Sera Prognostics Enters into Agreement with LabCorp 48

Interpace Diagnostics Extends Agreement with LabCorp 49

Sequenom enters into an Agreement with University of California 50

Sysmex Enters into Co-Development Agreement with LabCorp 51

Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 52

Gamma-Dynacare Medical Labs Enters Into Agreement With OSR Medical 53

Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 54

Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 55

Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 56

CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests 57

CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests 58

Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 59

XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 60

Equity Offering 61

MC10 Raises Funds through Private Placement of Shares 61

LipoScience Completes IPO For USD 52 Million 62

Sequenom Completes Public Offering Of Common Stock For USD 62 Million 64

Debt Offering 66

LabCorp Raises USD600 Million in Public Offering of 3.6% Notes Due 2027 66

LabCorp Raises USD600 Million in Public Offering of 3.25% Notes Due 2024 68

LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 70

LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 72

LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 74

LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 76

LabCorp Completes Public Offering Of Notes Due 2018 For USD 400 Million 78

LabCorp Completes Public Offering Of Notes Due 2023 For USD 300 Million 80

Sequenom Completes Private Placement Of Notes Due 2017 For USD 130 Million 82

LabCorp Completes Public Offering Of Senior Notes Due 2017 For USD 500 Million 83

LabCorp Completes Public Offering Of Senior Notes Due 2022 For USD 500 Million 85

Asset Transactions 87

Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 87

Marken Acquires European Kit Building Operation Facility From LabCorp 88

Acquisition 89

Eurofins Acquires Covance from LabCorp 89

LabCorp Acquires Sciformix 91

LabCorp Acquires Pathology Associates Medical Labs from Providence Health & Services and Catholic Health Initiatives 92

LabCorp Acquires ClearPath Diagnostics from Shore Capital Partners 94

LabCorp Acquires Sequenom 95

LabCorp Acquires Covance for USD6.1 Billion 97

LabCorp Acquires Bode Technology from SolutionPoint 99

LabCorp Acquires LipoScience for USD85.3 Million 100

Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 102

Gamma-Dynacare Medical Labs Acquires Controlling Interest In Impact Genetics 103

LabCorp Acquires Minority Stake In SynapDx For USD 2 Million 104

LabCorp Completes Acquisition Of Medtox Scientific For USD 241 Million 105

Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 107

Laboratory Corp of America Holdings-Key Competitors 108

Laboratory Corp of America Holdings-Key Employees 109

Laboratory Corp of America Holdings-Locations And Subsidiaries 110

Head Office 110

Other Locations & Subsidiaries 110

Recent Developments 115

Strategy And Business Planning 115

Jun 01, 2018: LabCorp and Unilabs Collaborate to Expand Global Reach of Precision Medicine Capabilities to Serve Patients, Physicians and Pharma 115

Jun 14, 2017: Covance Opens State-of-the-Art Laboratory for Companion Diagnostics 116

Apr 21, 2017: Covance to Expand Large-Molecule Development Capabilities in the UK 117

Financial Announcements 118

Jul 25, 2018: LabCorp Announces 2018 Second Quarter Results and Updates 2018 Guidance 118

Apr 25, 2018: LabCorp Announces Strong 2018 First Quarter Results and Updates 2018 Guidance 120

Feb 06, 2018: LabCorp Reports Net Revenue Of USD 2.70 Billion In The Fourth Quarter 2017 123

Oct 25, 2017: LabCorp Announces Record Third Quarter Results and Increases 2017 Guidance 126

Jul 26, 2017: LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance 128

Apr 25, 2017: Laboratory Corporation of America Holdings Announces 2017 First Quarter Results and Updates 2017 Guidance 131

Feb 16, 2017: Laboratory Corporation of America Holdings Announces Record 2016 Fourth Quarter and Full Year Results and Provides 2017 Guidance 133

Corporate Communications 136

Jul 12, 2018: Robert E. Mittelstaedt, Jr. to Retire from LabCorp Board of Directors and Current Board Member Adam H. Schechter to Assume Role of Lead Independent Director in 2019 136

Nov 13, 2017: LabCorp Receives 2017 Partnership Award from Be The Match 137

Aug 24, 2017: LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer 138

Jul 18, 2017: LabCorp's William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center 139

Mar 29, 2017: LabCorp Promotes Executive Gary Huff to CEO of LabCorp Diagnostics, One of the Company's Two Primary Business Segments 140

Legal and Regulatory 141

Jun 15, 2017: Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation 141

Product News 142

Nov 16, 2017: Cority Enhances Clinical Testing Solution with LabCorp Interface 142

Sep 14, 2017: LabCorp Presents Nine Studies, Including Novel Research on Improving Genetic Counseling Quality, at the National Society of Genetic Counselors Annual Conference 143

Apr 28, 2017: LabCorp to Exclusively Offer the M3 Checklist, a Multi-Condition Mental Health Screening Tool 144

Other Significant Developments 146

May 25, 2018: LabCorp to Become a Preferred National Laboratory for Aetna 146

May 01, 2018: LabCorp Announces Collaboration with The Recovery Platform to Assist Physicians Treating Patients with Opioid Dependency 147

Sep 25, 2017: LabCorp Objects to Proposed PAMA 2018 Medicare Payment Rates for Clinical Laboratory Tests; Calls for Delay in Implementation to Avoid Significant Harm to Medicare Beneficiaries 148

Jul 11, 2017: LabCorp and Novant Health Extend Laboratory Services Agreement 149

Jun 28, 2017: Walgreens and LabCorp Collaborate to Bring Patient Service Centers for Laboratory Testing to Select Walgreens Stores 150

Appendix 151

Methodology 151

About GlobalData 151

Contact Us 151

Disclaimer 151


List Of Figure

List of Figures

Laboratory Corp of America Holdings, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Laboratory Corp of America Holdings, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Laboratory Corp of America Holdings, Medical Equipment, Deals by Type, 2012 to YTD 2018 9

Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Laboratory Corp of America Holdings, Medical Equipment, Deals by Market, 2012 to YTD 2018 11


List Of Table

List of Tables

Laboratory Corp of America Holdings, Medical Equipment, Key Facts, 2017 2

Laboratory Corp of America Holdings, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Laboratory Corp of America Holdings, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Laboratory Corp of America Holdings, Medical Equipment Deals By Type, 2012 to YTD 2018 9

Laboratory Corp of America Holdings, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Laboratory Corp of America Holdings, Deals By Market, 2012 to YTD 2018 11

Laboratory Corp of America Holdings, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million 17

Pharma Tech Solutions Acquires Genstrip From Shasta Technologies 19

Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For USD 1.3 Million 20

Orig3n Raises Funds through Initial Closing of Series B Financing 21

OmniSeq Plans to Raise Funds through Series B Financing 23

Sera Prognostics Raises USD40 Million in Series C Financing 24

Seventh Sense Biosystems Raises USD10 Million in Series C Financing 25

Ativa Medical Raises USD15 Million in Series B Financing 27

Vivify Health Raises Funds in Series B Venture Financing 29

Seventh Sense Biosystems Raises USD16 Million in Series B Financing 30

Flatiron Health Raises USD 130 Million In Series B Financing 32

Flatiron Health Raises USD 8 Million In Series A Financing 34

Decision Diagnostics Plans to Raise USD4.7 Million in Financing 36

LabCorp Enters into Licensing Agreement with MDNA Life Sciences 37

Sequenom Enters into Licensing Agreement with Mayo Medical Labs 38

Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS 39

Ingenuity Systems Enters Into Licensing Agreement With LabCorp For Clinical Content And Applications 41

Sequella Enters Into Licensing Agreement With LabCorp For B-Smart Technology 42

LipoScience Enters Into Licensing Agreement With Cleveland Clinic 43

LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 44

Covance Enters into Strategic Technology Agreement with GlaxoSmithKline 45

MC10 Enters into Partnership with LabCorp 46

OmniSeq Enters into Distribution Agreement with Laboratory Corp of America 47

Sera Prognostics Enters into Agreement with LabCorp 48

Interpace Diagnostics Extends Agreement with LabCorp 49

Sequenom enters into an Agreement with University of California 50

Sysmex Enters into Co-Development Agreement with LabCorp 51

Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests 52

Gamma-Dynacare Medical Labs Enters Into Agreement With OSR Medical 53

Covance And Pathoquest Enter Into Agreement For Sequencing-Based Biosafety Assessments 54

Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus 55

Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing 56

CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests 57

CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests 58

Mitomics Enters Into Co-Marketing Agreement With LabCorp For Prostate Core Mitomic Test 59

XDx Enters Into Agreement With LabCorp To Develop Lupus Flare Predictor Test 60

MC10 Raises Funds through Private Placement of Shares 61

LipoScience Completes IPO For USD 52 Million 62

Sequenom Completes Public Offering Of Common Stock For USD 62 Million 64

LabCorp Raises USD600 Million in Public Offering of 3.6% Notes Due 2027 66

LabCorp Raises USD600 Million in Public Offering of 3.25% Notes Due 2024 68

LabCorp Raises USD500 Million in Public Offering of 2.625% Notes Due 2020 70

LabCorp Raises USD1 Billion in Public Offering of 3.6% Notes Due 2025 72

LabCorp Raises USD900 Million in Public Offering of 4.7% Notes Due 2045 74

LabCorp Raises USD500 Million in Public Offering of 3.2% Notes Due 2022 76

LabCorp Completes Public Offering Of Notes Due 2018 For USD 400 Million 78

LabCorp Completes Public Offering Of Notes Due 2023 For USD 300 Million 80

Sequenom Completes Private Placement Of Notes Due 2017 For USD 130 Million 82

LabCorp Completes Public Offering Of Senior Notes Due 2017 For USD 500 Million 83

LabCorp Completes Public Offering Of Senior Notes Due 2022 For USD 500 Million 85

Sequenom Plans to Sell Clinical Genomic Lab in North Carolina 87

Marken Acquires European Kit Building Operation Facility From LabCorp 88

Eurofins Acquires Covance from LabCorp 89

LabCorp Acquires Sciformix 91

LabCorp Acquires Pathology Associates Medical Labs from Providence Health & Services and Catholic Health Initiatives 92

LabCorp Acquires ClearPath Diagnostics from Shore Capital Partners 94

LabCorp Acquires Sequenom 95

LabCorp Acquires Covance for USD6.1 Billion 97

LabCorp Acquires Bode Technology from SolutionPoint 99

LabCorp Acquires LipoScience for USD85.3 Million 100

Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 102

Gamma-Dynacare Medical Labs Acquires Controlling Interest In Impact Genetics 103

LabCorp Acquires Minority Stake In SynapDx For USD 2 Million 104

LabCorp Completes Acquisition Of Medtox Scientific For USD 241 Million 105

Bode Technology Group Acquires Provider Of DNA Analysis Testing Services, Chromosomal Labs 107

Laboratory Corp of America Holdings, Key Competitors 108

Laboratory Corp of America Holdings, Key Employees 109

Laboratory Corp of America Holdings, Other Locations 110

Laboratory Corp of America Holdings, Subsidiaries 111

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Laboratory Corp of America Holdings, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.